mTOR抑制剂依维莫司联合低剂量阿糖胞苷用于老年急性髓系白血病的Ib期研究。 - Suppr | 超能文献

相似文献

1

Phase Ib study of the mTOR inhibitor everolimus with low dose cytarabine in elderly acute myeloid leukemia.mTOR抑制剂依维莫司联合低剂量阿糖胞苷用于老年急性髓系白血病的Ib期研究。

Leuk Lymphoma. 2018 Feb;59(2):493-496. doi: 10.1080/10428194.2017.1334122. Epub 2017 Jun 8.

2

A phase Ib GOELAMS study of the mTOR inhibitor RAD001 in association with chemotherapy for AML patients in first relapse.GOELAMS 研究的 Ib 期临床试验，评估 mTOR 抑制剂 RAD001 联合化疗治疗初发复发 AML 患者的疗效。

Leukemia. 2013 Jul;27(7):1479-86. doi: 10.1038/leu.2013.17. Epub 2013 Jan 16.

3

Low-dose homoharringtonine and cytarabine in combination with granulocyte colony-stimulating factor for elderly patients with de novo acute myeloid leukemia.小剂量高三尖杉酯碱和阿糖胞苷联合粒细胞集落刺激因子治疗老年初治急性髓系白血病

Leuk Lymphoma. 2015 Jan;56(1):141-6. doi: 10.3109/10428194.2014.910774. Epub 2014 Jun 16.

4

Lomustine in older patients with acute myeloid leukaemia.洛莫司汀用于老年急性髓系白血病患者。

Lancet Oncol. 2018 Nov;19(11):e584. doi: 10.1016/S1470-2045(18)30740-X. Epub 2018 Oct 4.

5

Panobinostat as part of induction and maintenance for elderly patients with newly diagnosed acute myeloid leukemia: phase Ib/II panobidara study.帕比司他用于新诊断急性髓系白血病老年患者诱导和维持治疗的研究：Ib/II期帕比达拉研究

Haematologica. 2015 Oct;100(10):1294-300. doi: 10.3324/haematol.2015.129577. Epub 2015 Jul 9.

6

Relapse and death during first remission in acute myeloid leukemia.急性髓系白血病首次缓解期的复发与死亡

Haematologica. 2008 Apr;93(4):633-4. doi: 10.3324/haematol.12366.

7

Comparison of Reduced-Intensity Idarubicin and Daunorubicin Plus Cytarabine as Induction Chemotherapy for Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia.低剂量伊达比星与柔红霉素加阿糖胞苷作为新诊断急性髓系白血病老年患者诱导化疗的比较

Clin Drug Investig. 2017 Feb;37(2):167-174. doi: 10.1007/s40261-016-0469-9.

8

Prognostic features for response and survival in elderly patients with de novo acute myeloid leukemia treated with mitoxantrone and intermediate dose cytarabine.米托蒽醌联合中剂量阿糖胞苷治疗老年初治急性髓系白血病的反应和生存预后特征

Leuk Lymphoma. 2005 Mar;46(3):367-75. doi: 10.1080/10428190400013076.

9

Using low-dose homoharringtonine and cytarabine in combination with granulocyte colony-stimulating factor in a priming induction therapy for acute myeloid leukemia: a retrospective study of 29 cases in china.

Leuk Lymphoma. 2017 Nov;58(11):2758-2761. doi: 10.1080/10428194.2017.1312378. Epub 2017 Apr 13.

10

Clofarabine Plus Low-Dose Cytarabine Is as Effective as and Less Toxic Than Intensive Chemotherapy in Elderly AML Patients.氯法拉滨联合小剂量阿糖胞苷在老年急性髓系白血病患者中与强化化疗疗效相当且毒性更低。

Clin Lymphoma Myeloma Leuk. 2016 Mar;16(3):163-8.e1-2. doi: 10.1016/j.clml.2015.11.016. Epub 2015 Nov 24.

引用本文的文献

1

Current Understanding of the Role of Autophagy in the Treatment of Myeloid Leukemia.自噬在髓性白血病治疗中的作用的研究现状。

Int J Mol Sci. 2024 Nov 14;25(22):12219. doi: 10.3390/ijms252212219.

2

The dual role of autophagy in acute myeloid leukemia.自噬在急性髓系白血病中的双重作用。

J Hematol Oncol. 2022 May 7;15(1):51. doi: 10.1186/s13045-022-01262-y.

3

Programmed cell death, redox imbalance, and cancer therapeutics.程序性细胞死亡、氧化还原失衡与癌症治疗